These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Chronically elevated plasma C-type natriuretic peptide level stimulates skeletal growth in transgenic mice. Kake T, Kitamura H, Adachi Y, Yoshioka T, Watanabe T, Matsushita H, Fujii T, Kondo E, Tachibe T, Kawase Y, Jishage K, Yasoda A, Mukoyama M, Nakao K. Am J Physiol Endocrinol Metab; 2009 Dec; 297(6):E1339-48. PubMed ID: 19808910 [Abstract] [Full Text] [Related]
3. Cyclic GMP-dependent protein kinase II plays a critical role in C-type natriuretic peptide-mediated endochondral ossification. Miyazawa T, Ogawa Y, Chusho H, Yasoda A, Tamura N, Komatsu Y, Pfeifer A, Hofmann F, Nakao K. Endocrinology; 2002 Sep; 143(9):3604-10. PubMed ID: 12193576 [Abstract] [Full Text] [Related]
4. Skeletal analysis of the long bone abnormality (lbab/lbab) mouse, a novel chondrodysplastic C-type natriuretic peptide mutant. Kondo E, Yasoda A, Tsuji T, Fujii T, Miura M, Kanamoto N, Tamura N, Arai H, Kunieda T, Nakao K. Calcif Tissue Int; 2012 Apr; 90(4):307-18. PubMed ID: 22271248 [Abstract] [Full Text] [Related]
8. Dwarfism and early death in mice lacking C-type natriuretic peptide. Chusho H, Tamura N, Ogawa Y, Yasoda A, Suda M, Miyazawa T, Nakamura K, Nakao K, Kurihara T, Komatsu Y, Itoh H, Tanaka K, Saito Y, Katsuki M, Nakao K. Proc Natl Acad Sci U S A; 2001 Mar 27; 98(7):4016-21. PubMed ID: 11259675 [Abstract] [Full Text] [Related]
10. Hypomorphic mutation in mouse Nppc gene causes retarded bone growth due to impaired endochondral ossification. Tsuji T, Kondo E, Yasoda A, Inamoto M, Kiyosu C, Nakao K, Kunieda T. Biochem Biophys Res Commun; 2008 Nov 07; 376(1):186-90. PubMed ID: 18775416 [Abstract] [Full Text] [Related]
11. Circulating osteocrin stimulates bone growth by limiting C-type natriuretic peptide clearance. Kanai Y, Yasoda A, Mori KP, Watanabe-Takano H, Nagai-Okatani C, Yamashita Y, Hirota K, Ueda Y, Yamauchi I, Kondo E, Yamanaka S, Sakane Y, Nakao K, Fujii T, Yokoi H, Minamino N, Mukoyama M, Mochizuki N, Inagaki N. J Clin Invest; 2017 Nov 01; 127(11):4136-4147. PubMed ID: 28990933 [Abstract] [Full Text] [Related]
14. C-type natriuretic peptide as a new regulator of food intake and energy expenditure. Inuzuka M, Tamura N, Yamada N, Katsuura G, Oyamada N, Taura D, Sonoyama T, Fukunaga Y, Ohinata K, Sone M, Nakao K. Endocrinology; 2010 Aug 01; 151(8):3633-42. PubMed ID: 20555027 [Abstract] [Full Text] [Related]
15. [C-type natriuretic peptide(CNP)--a novel stimulator of bone growth formed through endochondral ossification]. Yasoda A, Komatsu Y, Nakao K, Ogawa Y. Nihon Rinsho; 2004 Feb 01; 62 Suppl 2():77-81. PubMed ID: 15035100 [No Abstract] [Full Text] [Related]
16. Overexpression of the C-type natriuretic peptide (CNP) is associated with overgrowth and bone anomalies in an individual with balanced t(2;7) translocation. Bocciardi R, Giorda R, Buttgereit J, Gimelli S, Divizia MT, Beri S, Garofalo S, Tavella S, Lerone M, Zuffardi O, Bader M, Ravazzolo R, Gimelli G. Hum Mutat; 2007 Jul 01; 28(7):724-31. PubMed ID: 17373680 [Abstract] [Full Text] [Related]
19. Natriuretic peptide regulation of endochondral ossification. Evidence for possible roles of the C-type natriuretic peptide/guanylyl cyclase-B pathway. Yasoda A, Ogawa Y, Suda M, Tamura N, Mori K, Sakuma Y, Chusho H, Shiota K, Tanaka K, Nakao K. J Biol Chem; 1998 May 08; 273(19):11695-700. PubMed ID: 9565590 [Abstract] [Full Text] [Related]
20. C-type natriuretic peptide/guanylate cyclase B system in ATDC5 cells, a chondrogenic cell line. Suda M, Tanaka K, Yasoda A, Komatsu Y, Chusho H, Miura M, Tamura N, Ogawa Y, Nakao K. J Bone Miner Metab; 2002 May 08; 20(3):136-41. PubMed ID: 11984695 [Abstract] [Full Text] [Related] Page: [Next] [New Search]